Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AVITA Medical (RCEL) Income from Continuing Operations (2018 - 2025)

AVITA Medical filings provide 8 years of Income from Continuing Operations readings, the most recent being 11621000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations changed 0.39% to 11621000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 48587000.0, a 21.42% increase, with the full-year FY2025 number at 48587000.0, up 21.42% from a year prior.
  • Income from Continuing Operations hit 11621000.0 in Q4 2025 for AVITA Medical, up from 13187000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 37626000.0 in Q4 2023 to a low of 18658000.0 in Q1 2024.
  • Median Income from Continuing Operations over the past 5 years was 9691500.0 (2022), compared with a mean of 7683944.44.
  • Biggest five-year swings in Income from Continuing Operations: soared 785.6% in 2023 and later plummeted 130.77% in 2024.
  • AVITA Medical's Income from Continuing Operations stood at 5948000.0 in 2021, then grew by 7.73% to 5488000.0 in 2022, then soared by 785.6% to 37626000.0 in 2023, then crashed by 130.77% to 11576000.0 in 2024, then fell by 0.39% to 11621000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 11621000.0 (Q4 2025), 13187000.0 (Q3 2025), and 9920000.0 (Q2 2025) per Business Quant data.